nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—bile duct cancer	0.943	1	CbGaD
Lidocaine—SCN2A—Developmental Biology—NRAS—bile duct cancer	5.68e-05	0.001	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—NRAS—bile duct cancer	5.68e-05	0.001	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—NRAS—bile duct cancer	5.68e-05	0.001	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—KRAS—bile duct cancer	5.66e-05	0.001	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—KRAS—bile duct cancer	5.66e-05	0.001	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—EGFR—bile duct cancer	5.63e-05	0.000995	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—NRAS—bile duct cancer	5.63e-05	0.000994	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—FAR2—bile duct cancer	5.63e-05	0.000994	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—HRAS—bile duct cancer	5.62e-05	0.000992	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—NRAS—bile duct cancer	5.61e-05	0.00099	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	5.6e-05	0.000989	CbGpPWpGaD
Lidocaine—EGFR—Disease—IDH1—bile duct cancer	5.59e-05	0.000987	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—IL6—bile duct cancer	5.58e-05	0.000984	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—IL6—bile duct cancer	5.58e-05	0.000984	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—KRAS—bile duct cancer	5.57e-05	0.000984	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TGFB1—bile duct cancer	5.55e-05	0.000981	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—IL6—bile duct cancer	5.55e-05	0.00098	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—TGFB1—bile duct cancer	5.5e-05	0.00097	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—NRAS—bile duct cancer	5.48e-05	0.000967	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—NRAS—bile duct cancer	5.4e-05	0.000953	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—EGFR—bile duct cancer	5.39e-05	0.000951	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—IL6—bile duct cancer	5.38e-05	0.000949	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—KRAS—bile duct cancer	5.32e-05	0.00094	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—KRAS—bile duct cancer	5.32e-05	0.00094	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—NRAS—bile duct cancer	5.31e-05	0.000937	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—FAR2—bile duct cancer	5.3e-05	0.000936	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MMP2—bile duct cancer	5.3e-05	0.000936	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—KRAS—bile duct cancer	5.3e-05	0.000935	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	5.3e-05	0.000935	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—bile duct cancer	5.29e-05	0.000934	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—TGFB1—bile duct cancer	5.28e-05	0.000932	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—TGFB1—bile duct cancer	5.28e-05	0.000932	CbGpPWpGaD
Lidocaine—CYP2A6—NRF2 pathway—TGFB1—bile duct cancer	5.27e-05	0.000931	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—KRAS—bile duct cancer	5.27e-05	0.00093	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—FAR2—bile duct cancer	5.26e-05	0.000928	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—KRAS—bile duct cancer	5.25e-05	0.000926	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—EGFR—bile duct cancer	5.18e-05	0.000914	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—EGFR—bile duct cancer	5.18e-05	0.000914	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—bile duct cancer	5.17e-05	0.000913	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—KRAS—bile duct cancer	5.14e-05	0.000908	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—ERBB2—bile duct cancer	5.13e-05	0.000906	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	5.13e-05	0.000905	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TGFB1—bile duct cancer	5.09e-05	0.000899	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—KRAS—bile duct cancer	5.09e-05	0.000899	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	5.08e-05	0.000896	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—ERBB2—bile duct cancer	5.06e-05	0.000894	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—IDH2—bile duct cancer	5.04e-05	0.00089	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—HRAS—bile duct cancer	5.03e-05	0.000888	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	5.01e-05	0.000885	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—EGFR—bile duct cancer	4.99e-05	0.000881	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—bile duct cancer	4.98e-05	0.000879	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	4.97e-05	0.000877	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	4.96e-05	0.000875	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	4.93e-05	0.000871	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—KRAS—bile duct cancer	4.93e-05	0.000871	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—KRAS—bile duct cancer	4.93e-05	0.000871	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—EGFR—bile duct cancer	4.92e-05	0.000868	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	4.91e-05	0.000866	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—KRAS—bile duct cancer	4.89e-05	0.000863	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—KRAS—bile duct cancer	4.89e-05	0.000863	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—KRAS—bile duct cancer	4.89e-05	0.000863	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—KRAS—bile duct cancer	4.85e-05	0.000856	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—KRAS—bile duct cancer	4.83e-05	0.000852	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—IL6—bile duct cancer	4.82e-05	0.00085	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—HRAS—bile duct cancer	4.81e-05	0.00085	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—HRAS—bile duct cancer	4.74e-05	0.000836	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—KRAS—bile duct cancer	4.72e-05	0.000833	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—KRAS—bile duct cancer	4.65e-05	0.00082	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—ERBB2—bile duct cancer	4.65e-05	0.00082	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	4.64e-05	0.00082	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—IDH2—bile duct cancer	4.62e-05	0.000815	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—IL6—bile duct cancer	4.61e-05	0.000813	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—bile duct cancer	4.57e-05	0.000807	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—KRAS—bile duct cancer	4.57e-05	0.000806	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RNF43—bile duct cancer	4.55e-05	0.000804	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MET—bile duct cancer	4.54e-05	0.000801	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—IL6—bile duct cancer	4.53e-05	0.0008	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—HRAS—bile duct cancer	4.52e-05	0.000799	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—HRAS—bile duct cancer	4.52e-05	0.000799	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	4.5e-05	0.000795	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—HRAS—bile duct cancer	4.5e-05	0.000795	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—FAR2—bile duct cancer	4.49e-05	0.000793	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—HRAS—bile duct cancer	4.48e-05	0.000791	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—HRAS—bile duct cancer	4.46e-05	0.000787	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	4.39e-05	0.000776	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	4.37e-05	0.000772	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MMP9—bile duct cancer	4.34e-05	0.000767	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—IDH1—bile duct cancer	4.33e-05	0.000765	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—IL6—bile duct cancer	4.33e-05	0.000764	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—IL6—bile duct cancer	4.33e-05	0.000764	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—HRAS—bile duct cancer	4.33e-05	0.000764	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—IL6—bile duct cancer	4.31e-05	0.000761	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—SLC5A5—bile duct cancer	4.3e-05	0.000759	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—IL6—bile duct cancer	4.29e-05	0.000757	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—IL6—bile duct cancer	4.27e-05	0.000753	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	4.24e-05	0.000748	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	4.22e-05	0.000746	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—HRAS—bile duct cancer	4.19e-05	0.00074	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—HRAS—bile duct cancer	4.19e-05	0.00074	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	4.19e-05	0.00074	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—HRAS—bile duct cancer	4.16e-05	0.000734	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—HRAS—bile duct cancer	4.16e-05	0.000734	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—HRAS—bile duct cancer	4.16e-05	0.000734	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—IL6—bile duct cancer	4.14e-05	0.000731	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	4.13e-05	0.000728	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—HRAS—bile duct cancer	4.12e-05	0.000727	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—HRAS—bile duct cancer	4.1e-05	0.000724	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—IL6—bile duct cancer	4.01e-05	0.000709	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	4.01e-05	0.000709	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—IL6—bile duct cancer	4.01e-05	0.000709	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—HRAS—bile duct cancer	4.01e-05	0.000708	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MMP9—bile duct cancer	3.99e-05	0.000704	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—IL6—bile duct cancer	3.98e-05	0.000702	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—IL6—bile duct cancer	3.98e-05	0.000702	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—IL6—bile duct cancer	3.98e-05	0.000702	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—IDH1—bile duct cancer	3.97e-05	0.000701	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—HRAS—bile duct cancer	3.96e-05	0.0007	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—HRAS—bile duct cancer	3.95e-05	0.000697	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—IL6—bile duct cancer	3.94e-05	0.000696	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—IL6—bile duct cancer	3.93e-05	0.000693	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—NRAS—bile duct cancer	3.91e-05	0.000689	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—HRAS—bile duct cancer	3.88e-05	0.000685	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—NRAS—bile duct cancer	3.85e-05	0.00068	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—IL6—bile duct cancer	3.84e-05	0.000677	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MMP2—bile duct cancer	3.78e-05	0.000668	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—IL6—bile duct cancer	3.78e-05	0.000667	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—IDH2—bile duct cancer	3.73e-05	0.000658	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	3.71e-05	0.000656	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—IDH2—bile duct cancer	3.64e-05	0.000643	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	3.59e-05	0.000634	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TGFB1—bile duct cancer	3.58e-05	0.000632	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	3.58e-05	0.000632	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	3.56e-05	0.000628	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—NRAS—bile duct cancer	3.53e-05	0.000624	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—bile duct cancer	3.51e-05	0.00062	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	3.5e-05	0.000618	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—FAR2—bile duct cancer	3.47e-05	0.000612	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	3.44e-05	0.000607	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—GNAS—bile duct cancer	3.4e-05	0.0006	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—KRAS—bile duct cancer	3.36e-05	0.000593	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GNAS—bile duct cancer	3.34e-05	0.00059	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.33e-05	0.000588	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—KRAS—bile duct cancer	3.32e-05	0.000585	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—ERBB2—bile duct cancer	3.32e-05	0.000585	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—IDH1—bile duct cancer	3.2e-05	0.000566	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—IDH2—bile duct cancer	3.16e-05	0.000557	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—IDH1—bile duct cancer	3.13e-05	0.000553	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—KRAS—bile duct cancer	3.04e-05	0.000537	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFBR2—bile duct cancer	2.97e-05	0.000525	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HGF—bile duct cancer	2.96e-05	0.000522	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ERBB2—bile duct cancer	2.93e-05	0.000517	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—SLC5A5—bile duct cancer	2.86e-05	0.000505	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—bile duct cancer	2.86e-05	0.000504	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MMP9—bile duct cancer	2.84e-05	0.000502	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—bile duct cancer	2.82e-05	0.000498	CbGpPWpGaD
Lidocaine—EGFR—Disease—SMAD4—bile duct cancer	2.81e-05	0.000497	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ERBB2—bile duct cancer	2.81e-05	0.000496	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—IDH2—bile duct cancer	2.75e-05	0.000485	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—IL6—bile duct cancer	2.73e-05	0.000483	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—IDH1—bile duct cancer	2.71e-05	0.000479	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—IL6—bile duct cancer	2.7e-05	0.000476	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—SLC5A5—bile duct cancer	2.62e-05	0.000463	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—IDH2—bile duct cancer	2.59e-05	0.000457	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.59e-05	0.000457	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—bile duct cancer	2.59e-05	0.000456	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—IDH2—bile duct cancer	2.57e-05	0.000453	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	2.53e-05	0.000447	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NRAS—bile duct cancer	2.52e-05	0.000445	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	2.48e-05	0.000438	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—IL6—bile duct cancer	2.47e-05	0.000437	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—IDH1—bile duct cancer	2.36e-05	0.000417	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TGFB1—bile duct cancer	2.34e-05	0.000414	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	2.34e-05	0.000414	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—NRAS—bile duct cancer	2.23e-05	0.000393	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—IDH1—bile duct cancer	2.23e-05	0.000393	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GNAS—bile duct cancer	2.22e-05	0.000392	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—IDH1—bile duct cancer	2.21e-05	0.00039	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—IDH2—bile duct cancer	2.19e-05	0.000387	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—KRAS—bile duct cancer	2.17e-05	0.000383	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—NRAS—bile duct cancer	2.14e-05	0.000378	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SLC5A5—bile duct cancer	2.11e-05	0.000373	CbGpPWpGaD
Lidocaine—EGFR—Disease—NOS2—bile duct cancer	2.09e-05	0.00037	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	2.08e-05	0.000368	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFBR2—bile duct cancer	2.08e-05	0.000367	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SLC5A5—bile duct cancer	2.07e-05	0.000365	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GNAS—bile duct cancer	2.04e-05	0.000359	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNAS—bile duct cancer	2.01e-05	0.000354	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SMAD4—bile duct cancer	1.97e-05	0.000348	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KRAS—bile duct cancer	1.92e-05	0.000338	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—IDH1—bile duct cancer	1.89e-05	0.000333	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—bile duct cancer	1.85e-05	0.000326	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KRAS—bile duct cancer	1.84e-05	0.000325	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS2—bile duct cancer	1.79e-05	0.000317	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SLC5A5—bile duct cancer	1.79e-05	0.000316	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—IL6—bile duct cancer	1.77e-05	0.000312	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB2—bile duct cancer	1.71e-05	0.000301	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—IDH2—bile duct cancer	1.69e-05	0.000299	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.68e-05	0.000296	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GNAS—bile duct cancer	1.64e-05	0.00029	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—bile duct cancer	1.63e-05	0.000288	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GNAS—bile duct cancer	1.61e-05	0.000284	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB2—bile duct cancer	1.57e-05	0.000278	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—bile duct cancer	1.56e-05	0.000276	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—IL6—bile duct cancer	1.56e-05	0.000275	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SLC5A5—bile duct cancer	1.56e-05	0.000275	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTGS2—bile duct cancer	1.54e-05	0.000272	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SLC5A5—bile duct cancer	1.47e-05	0.000259	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SLC5A5—bile duct cancer	1.46e-05	0.000257	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—IDH1—bile duct cancer	1.46e-05	0.000257	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—NRAS—bile duct cancer	1.42e-05	0.000251	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GNAS—bile duct cancer	1.39e-05	0.000246	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.37e-05	0.000241	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NRAS—bile duct cancer	1.3e-05	0.000229	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC5A5—bile duct cancer	1.24e-05	0.00022	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—bile duct cancer	1.22e-05	0.000216	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GNAS—bile duct cancer	1.21e-05	0.000214	CbGpPWpGaD
Lidocaine—EGFR—Disease—NRAS—bile duct cancer	1.2e-05	0.000211	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—bile duct cancer	1.19e-05	0.000211	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.17e-05	0.000206	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GNAS—bile duct cancer	1.14e-05	0.000202	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GNAS—bile duct cancer	1.13e-05	0.0002	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—bile duct cancer	1.12e-05	0.000197	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—bile duct cancer	1.11e-05	0.000197	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB2—bile duct cancer	1.1e-05	0.000195	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—bile duct cancer	1.09e-05	0.000193	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—bile duct cancer	1.04e-05	0.000183	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—bile duct cancer	1.03e-05	0.000182	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—bile duct cancer	9.94e-06	0.000176	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GNAS—bile duct cancer	9.67e-06	0.000171	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC5A5—bile duct cancer	9.61e-06	0.00017	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—bile duct cancer	9.49e-06	0.000168	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—bile duct cancer	9.46e-06	0.000167	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—bile duct cancer	9.08e-06	0.00016	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—bile duct cancer	8.82e-06	0.000156	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—bile duct cancer	8.76e-06	0.000155	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—bile duct cancer	8.62e-06	0.000152	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NRAS—bile duct cancer	8.39e-06	0.000148	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—bile duct cancer	8.39e-06	0.000148	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—bile duct cancer	7.79e-06	0.000138	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—bile duct cancer	7.47e-06	0.000132	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNAS—bile duct cancer	7.47e-06	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—bile duct cancer	7.22e-06	0.000127	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—bile duct cancer	6.51e-06	0.000115	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—bile duct cancer	6.42e-06	0.000113	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—bile duct cancer	6.14e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—bile duct cancer	6.13e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—bile duct cancer	6.08e-06	0.000107	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—bile duct cancer	5.87e-06	0.000104	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—bile duct cancer	5.2e-06	9.17e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—bile duct cancer	4.01e-06	7.08e-05	CbGpPWpGaD
